Search research articles
Contact Us
Filters
Showing results (31-40 of 159) with videos related to
Page
of 16
Sort By:
Nature Communications
|
February 6, 2021
The effects of releasing early results from ongoing clinical trials
Steffen Ventz, Sergio Bacallado, Rifaquat Rahman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials
Rifaquat Rahman, Steffen Ventz, Robert Redd, et al.
Annals of Surgical Oncology
|
April 18, 2013
Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins
Melin J Khandekar, Chandrajit P Raut, Jason L Hornick, et al.
Neuro-Oncology
|
January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology
Daniel N Cagney, Joohee Sul, Raymond Y Huang, et al.
JCO Precision Oncology
|
February 27, 2023
Validation of Predictive Analyses for Interim Decisions in Clinical Trials
Alejandra Avalos-Pacheco, Steffen Ventz, Andrea Arfè, et al.
Journal of Neuro-Oncology
|
May 21, 2017
Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge
Daniel N Cagney, Brian M Alexander, F Stephen Hodi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastoma
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2013
Reply to B. Freidlin et al
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
Cancer
|
September 16, 2011
Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors
Paul J Kelly, Nancy U Lin, Elizabeth B Claus, et al.
Journal of Neuro-Oncology
|
July 13, 2016
Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge
Daniel N Cagney, Brian M Alexander, F Stephen Hodi, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 159) with videos related to
Sort By:
Page
of 16
Nature Communications
|
February 6, 2021
The effects of releasing early results from ongoing clinical trials
Steffen Ventz, Sergio Bacallado, Rifaquat Rahman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials
Rifaquat Rahman, Steffen Ventz, Robert Redd, et al.
Annals of Surgical Oncology
|
April 18, 2013
Paratesticular liposarcoma: unusual patterns of recurrence and importance of margins
Melin J Khandekar, Chandrajit P Raut, Jason L Hornick, et al.
Neuro-Oncology
|
January 3, 2018
The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology
Daniel N Cagney, Joohee Sul, Raymond Y Huang, et al.
JCO Precision Oncology
|
February 27, 2023
Validation of Predictive Analyses for Interim Decisions in Clinical Trials
Alejandra Avalos-Pacheco, Steffen Ventz, Andrea Arfè, et al.
Journal of Neuro-Oncology
|
May 21, 2017
Erratum to: Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge
Daniel N Cagney, Brian M Alexander, F Stephen Hodi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Bayesian adaptive randomized trial design for patients with recurrent glioblastoma
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 9, 2013
Reply to B. Freidlin et al
Lorenzo Trippa, Eudocia Q Lee, Patrick Y Wen, et al.
Cancer
|
September 16, 2011
Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors
Paul J Kelly, Nancy U Lin, Elizabeth B Claus, et al.
Journal of Neuro-Oncology
|
July 13, 2016
Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge
Daniel N Cagney, Brian M Alexander, F Stephen Hodi, et al.
Page
of 16